Designation of people with intellectual and developmental disabilities as a medically underserved population would not solve problems of access to care.

Women with disabilities may be prevented access to reproductive medicine due to discrimination and mistaken assumptions about disabled people.

Clinicians with obligations to patients and to organizations often assess patients in law enforcement for both therapeutic and nontherapeutic purposes.

Heightened privacy and confidentiality stakes generate unique anonymity and nondisclosure policies and practices for HIV.

Physicians must resist judging the quality of life of their patients with Down syndrome and learn to listen and see them as individual personalities.

If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.

Dr Charles Binkley joins Ethics Talk to discuss his article, coauthored with Michael Politz and Dr Brian Green: "Who, If Not the FDA, Should Regulate Implantable Brain-Computer Interface Devices?"

When a parent resists a physician's recommendation for a pediatric patient, physician-parent partnering can promote the patient's best interest and help encourage lifestyle changes.

When patients cannot give informed consent or refusal for antipsychotic medication, physicians must meet specific criteria to justify temporarily withholding a diagnosis.

Researchers and clinicians face ethical and policy-based challenges in disclosing, preventing and treating psychosis. Which diagnostic labels should be considered to motivate more effective public and professional dialogue about psychosis risk?